SAM #CDC-OTA-SSN-26-0001

CDC OTA Opportunity: Annual Asbestos Disease Screening, Innovation, and Research for Libby/Troy, Montana

This opportunity is for organizations to partner with the CDC under Other Transaction Authority (OTA) to deliver and innovate asbestos-related disease (ARD) screening and outreach for residents of Libby and Troy, Montana exposed to asbestos-contaminated vermiculite. - Annual health screenings for ARDs, including spirometry, chest radiographs (B-reader interpretation), high-resolution CT scans, low-dose CT for lung cancer, and other tests (e.g., fecal immunochemical, autoimmune markers) - Outreach and education to eligible individuals locally and nationally via a distributed provider network - Technological innovation: pilot and scale emerging diagnostic tools (AI-assisted imaging, telehealth, data integration platforms) - Develop and validate AI/machine learning models for ARD detection - Evaluate and integrate new diagnostic tests - Strategic research: analyze demographic/exposure data, forecast screening needs, develop triggers for program scaling, and plan for local healthcare integration - Update protocols and educational materials based on scientific findings - Estimated funding up to $34 million annually; program expected to run through 2032 with screening numbers declining over time - Key requirements: financial stability, audit history disclosure, federal eligibility - Success metrics: screening volume, notification timeliness, referral success, AI diagnostic accuracy

Description

The Government anticipates this opportunity to be conducted through the CDC's OTA Authority. --- Please see attached Other Transaction Authority Sources Sought document for details regarding an opportunity in Libby, Montana for Asbestos Related Disease Asbestos Screening, Innovation, and Transition Program where the CDC seeks to modernize and renew the long-term screening and outreach strategy with predictive modeling and data analytics.

The program will include 3 components -

1. Screening and Outreach

To provide annual health screenings for asbestos-related diseases (ARDs) (e.g., pleural plaque, asbestosis, lung cancer, mesothelioma) and other associated conditions and to support the community in seeking care. As part of this effort, conduct education and awareness to reach eligible individuals.

2. Technological Innovation

Identify, test, and integrate new diagnostic tools, digital health platforms, or data-sharing technologies that improve the accuracy and efficiency of asbestos-related disease detection.

3. Strategic Research and Community Legacy

Analyze demographic and exposure data to forecast future screening requirements. Develop data-driven triggers and timelines for the future of the program. Design a strategy that helps ensure local healthcare infrastructure can support impacted residents and integrate into services long term. --- Attached: 1. Combined File: OTA Sources Sought and DRAFT Statement of Objectives. --- For any clarifying questions please email BOTH: 1. Ted Larson - Lead Epidemiologist - THL3@CDC.GOV AND 2. Emilio Cibula - Agreements Officer - AHR0@CDC.GOV

View original listing